Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strand Life Sciences provides CAP-accredited genomic and multiomics testing, bioinformatics analysis and clinical reporting services to hospitals, diagnostic labs, pharmaceutical and biotechnology customers. It commercializes software platforms for next-generation sequencing (NGS) and omics data analysis (e.g., StrandNGS, GeneSpring) and operates oncology and hereditary risk diagnostic services, rather than drug-development trials[2][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strand Diagnostics.